A pharmacy computer system should generate an alert if a pharmacy technician tries to process which of the following pairs of medication for the same patient?
Janumet and Eliquis should trigger an alert in a pharmacy computer system.
Janumet is a combination medication containing metformin and sitagliptin, used to manage blood sugar levels in diabetes, while Eliquis is an anticoagulant that increases the risk of bleeding. Administering both medications simultaneously raises significant safety concerns due to the potential for increased bleeding complications in patients with diabetes.
This combination is particularly concerning as Janumet manages blood sugar levels, while Eliquis is an anticoagulant. The use of these two medications together can heighten the risk of serious bleeding events, especially in patients with diabetes, making it essential for the pharmacy system to alert the technician.
Lasix (furosemide) is a diuretic, and Crestor (rosuvastatin) is a statin used for lowering cholesterol. While both medications can be prescribed concurrently, they do not present significant interaction risks that would necessitate an alert. They are commonly used together in patients with heart failure or hypertension, where monitoring of kidney function and lipid levels is standard.
Pepcid (famotidine) is an H2 blocker used for treating ulcers and gastroesophageal reflux disease, while Claritin (loratadine) is an antihistamine for allergy relief. There are no known interactions or significant risks associated with using these medications together, so an alert is not warranted.
Cortef (hydrocortisone) is a corticosteroid, and Premarin (conjugated estrogens) is used for hormone replacement therapy. Although both medications may be prescribed to the same patient, they do not interact in a way that poses a high risk of adverse effects, and thus, an alert is not necessary.
The pharmacy computer system must prioritize patient safety by generating alerts for potentially harmful drug interactions. In this case, the combination of Janumet and Eliquis presents a notable risk due to the increased likelihood of bleeding in patients, making it critical for pharmacy technicians to receive warnings when processing these medications together. Other combinations listed do not pose the same level of risk, highlighting the importance of targeted alerts in ensuring safe medication management.
Related Questions
View allMethotrexate is indicated to treat:
A vial of antibiotic for IM injection contains 1 g in 3 mL. What is th...
When a drug recall notice is received, the pharmacy technician should:
In order to administer Lantus SoloStar, the patient will require a(n):
Which of the following is considered a high-alert medication because i...
Related Quizzes
View allPharmacy Technician Certification Exam PTCE
PTCE Pharmacy Technician Certification Exam
PTCE Blue Print for Pharmacy Technician Certification
Pharmacy Technician Certification Exam PTCE Blueprint
Pharmacy Technician Certification Exam PTCE Practice Questions
Pharmacy Technician Certification Exam Answers
PTCE With Online Test Pharmacy Technician Certification Exam
Certified Pharmacy Technician Certification
Pharmacy Technician Certification Board Practice Exam
Pharmacy Technician Certification Exam Practice Test
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations